Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2010
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Antidepressive Agents, Second-Generation (MeSH)
- Antineoplastic Agents, Hormonal (MeSH)
- Breast Neoplasms (MeSH)
- Cytochrome P-450 CYP2D6 (MeSH)
- Cytochrome P-450 CYP2D6 Inhibitors (MeSH)
- Drug Interactions (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Receptors, Estrogen (MeSH)
- Selective Serotonin Reuptake Inhibitors (MeSH)
- Serotonin Antagonists (MeSH)
- Tamoxifen (MeSH)
published in
- Breast Cancer Research Journal